Compounds > 1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone

Page last updated: 2024-09-03

1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone and cholecystokinin

1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone has been researched along with cholecystokinin in 11 studies

Compound Research Comparison

Studies (1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone)	Trials (1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone)	Recent Studies (post-2010) (1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone)	Studies (cholecystokinin)	Trials (cholecystokinin)	Recent Studies (post-2010) (cholecystokinin)
26	0	5	10,914	466	1,074

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	9 (81.82)	18.2507
2000's	2 (18.18)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Czachura, JF; Howbert, JJ; Rasmussen, K; Stockton, ME	2
Blanchard, JC; Böhme, GA; Lemaire, M; Piot, O; Roques, BP	1
Berger, JE; Helton, DR; Rasmussen, K; Scearce, E	2
Rasmussen, K	1
Howbert, JJ; Rasmussen, K; Stockton, ME	1
Ehlhardt, WJ; Woodland, JM	1
Izumi, T	1
Levin, L; Reisman, S; Siegel, A; Sitthisomwong, P; Weiner, S	1
Farook, JM; Lee, L; Moochhala, SM; Wang, Q; Wong, PT; Zhu, YZ	1

Reviews

1 review(s) available for 1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone and cholecystokinin

Article	Year
CCK, schizophrenia, and anxiety. CCK-B antagonists inhibit the activity of brain dopamine neurons. Annals of the New York Academy of Sciences, 1994, Mar-23, Volume: 713 Topics: Animals; Anxiety; Brain; Cholecystokinin; Dopamine; Haloperidol; Humans; Neurons; Pyrazoles; Receptors, Cholecystokinin; Schizophrenia	1994

Other Studies

10 other study(ies) available for 1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone and cholecystokinin

Article	Year
Cholecystokinin (CCK) and schizophrenia: the selective CCKB antagonist LY262691 decreases midbrain dopamine unit activity. European journal of pharmacology, 1991, Dec-10, Volume: 209, Issue:1-2 Topics: Animals; Antipsychotic Agents; Apomorphine; Cholecystokinin; Dopamine; Male; Mesencephalon; Neurons; Pyrazoles; Rats; Rats, Inbred Strains; Schizophrenia	1991
CCK-A and CCK-B selective receptor agonists and antagonists modulate olfactory recognition in male rats. Psychopharmacology, 1994, Volume: 115, Issue:4 Topics: Amino Acid Sequence; Animals; Benzodiazepinones; Cholecystokinin; Cognition; Indoles; Male; Meglumine; Molecular Sequence Data; Peptide Fragments; Phenylurea Compounds; Pyrazoles; Rats; Rats, Wistar; Receptors, Cholecystokinin; Sincalide; Smell; Social Behavior	1994
The CCK-B antagonist LY288513 blocks effects of diazepam withdrawal on auditory startle. Neuroreport, 1993, Nov-18, Volume: 5, Issue:2 Topics: Acoustic Stimulation; Animals; Cholecystokinin; Diazepam; Male; Pyrazoles; Rats; Reflex, Startle; Substance Withdrawal Syndrome	1993
The CCK-B antagonist LY288513 blocks diazepam-withdrawal-induced increases in auditory startle response. Annals of the New York Academy of Sciences, 1994, Mar-23, Volume: 713 Topics: Acoustic Stimulation; Animals; Cholecystokinin; Diazepam; Male; Pyrazoles; Rats; Receptors, Cholecystokinin; Reflex, Startle; Substance Withdrawal Syndrome; Time Factors	1994
Inhibition of A9 and A10 dopamine cells by the cholecystokinin-B antagonist LY262691: mediation through feedback pathways from forebrain sites. Synapse (New York, N.Y.), 1993, Volume: 15, Issue:2 Topics: Anesthesia; Animals; Cholecystokinin; Corpus Striatum; Dopamine; Feedback; Male; Microinjections; Neural Pathways; Nucleus Accumbens; Prefrontal Cortex; Prosencephalon; Pyrazoles; Radio Waves; Rats; Rats, Sprague-Dawley; Receptors, Dopamine	1993
Electrophysiological effects of diphenylpyrazolidinone cholecystokinin-B and cholecystokinin-A antagonists on midbrain dopamine neurons. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 264, Issue:1 Topics: Animals; Benzodiazepinones; Cholecystokinin; Dopamine; Electrophysiology; Male; Mesencephalon; Neurons; Phenylurea Compounds; Pyrazoles; Rats; Rats, Sprague-Dawley	1993
Characterization of an O-glucuronide metabolite of the CCK-B antagonist LY288513 and its plasma levels in mouse, rat, and dog. Drug metabolism and disposition: the biological fate of chemicals, 1995, Volume: 23, Issue:9 Topics: Animals; Biotransformation; Cholecystokinin; Chromatography, High Pressure Liquid; Dogs; Female; Glucuronates; Hormone Antagonists; Magnetic Resonance Spectroscopy; Male; Mice; Pyrazoles; Rats; Rats, Inbred F344; Species Specificity; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet	1995
[Behavioral and neurochemical study on the role of the brain cholecystokinin system in anxiety]. [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 1998, Volume: 73, Issue:5 Topics: Animals; Anxiety; Biogenic Monoamines; Brain; Cholecystokinin; Disease Models, Animal; Hormone Antagonists; Male; Proglumide; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin	1998
The effect of a cholecystokinin agonist on masseter muscle activity in the cat. Journal of dental research, 2000, Volume: 79, Issue:10 Topics: Animals; Behavior, Animal; Cats; Cholecystokinin; Dose-Response Relationship, Drug; Electric Stimulation; Electromyography; Female; Hormone Antagonists; Hypothalamus, Middle; Male; Masseter Muscle; Motor Activity; Pentagastrin; Pyrazoles; Rage; Reaction Time	2000
Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test apparatus. Neuroscience letters, 2004, Apr-01, Volume: 358, Issue:3 Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Benzodiazepines; Brain; Chemokines; Chemokines, CC; Cholecystokinin; Male; Maze Learning; Proglumide; Pyrazoles; Quinazolines; Quinazolinones; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Species Specificity; Tetragastrin	2004